Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance
Mayinuer Maitituoheti(The University of Texas MD Anderson Cancer Center), Kunal Rai(The University of Texas MD Anderson Cancer Center), Anand K. Singh(The University of Texas MD Anderson Cancer Center), Manrong Wu(The University of Texas MD Anderson Cancer Center), Stuart S. Levine(Massachusetts Institute of Technology), Nana Chen(Massachusetts Eye and Ear Infirmary), Jaime H. Cheah(Broad Institute), Patrick Hwu(Moffitt Cancer Center), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Alvin Shi(Broad Institute), Elizabeth M. Burton(The University of Texas MD Anderson Cancer Center), Sharmistha Sarkar(The University of Texas MD Anderson Cancer Center), Christopher Terranova(The University of Texas MD Anderson Cancer Center), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Chantale Bernatchez(BMC Software (United States)), Jiekun Yang(Rutgers, The State University of New Jersey), Apoorvi Chaudhri(Harvard University), Srinivas Vinod Saladi(Toledo Clinic Cancer Center), Giuseppe Tarantino(Ospedali Riuniti di Ancona), Nazanin Esmaeili Anvar(The University of Texas MD Anderson Cancer Center), Emily Z. Keung(The University of Texas MD Anderson Cancer Center), Christian K. Soule(Allen Institute), Jeffrey E. Gershenwald(The University of Texas MD Anderson Cancer Center), Caitlin Creasy(The University of Texas MD Anderson Cancer Center), Jared Malke(The University of Texas MD Anderson Cancer Center), Manolis Kellis(Broad Institute), Jiajia Chen(Dana-Farber Cancer Institute), Shan Jiang(Center for Excellence in Molecular Cell Science), Ming Tang(AstraZeneca (United States)), David Liu(University of Louisville), Li‐Lun Ho(Broad Institute), Lauren E. Haydu(The University of Texas MD Anderson Cancer Center), Kyriaki Galani(Massachusetts Institute of Technology), Genevieve M. Boland(Harvard University)
Cited by 4
Related Papers
Regulation of Ferroptotic Cancer Cell Death by GPX4
|Cell|2014|7.5k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k